Ribavirin treatment for crimean-congo hemorrhagic fever

Japanese Journal of Infectious Diseases

Volumn 62, Issue 6, 2009, Pages 485-486

  Leblebicioglu, Hakan ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RIBAVIRIN;

AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HIGH RISK POPULATION; HUMAN; IRAN; LETTER; SEROPREVALENCE; SURVIVAL; VIRUS HEMORRHAGIC FEVER;

ANTIVIRAL AGENTS; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; IRAN; RIBAVIRIN; TREATMENT OUTCOME;

EID: 75149193210     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Izadi, S. and Salehi, M. (2009): Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn. J. Infect. Dis., 62, 11-15.
2. Ergonul, O. (2008): Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res., 78, 125-131.
3. Whitehouse, C.A. (2004): Crimean-Congo hemorrhagic fever. Antiviral Res., 64, 145-160.
4. Gunes, T., Engin, A., Poyraz, O., et al. (2009): Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey. Emerg. Infect. Dis., 15, 461-464.
5. Vorou, R., Pierroutsakos, I.N. and Maltezou, H.C. (2007): Crimean-Congo hemorrhagic fever. Curr. Opin. Infect. Dis., 20, 495-500.
6. Sheikh, A.S., Sheikh, A.A., Sheikh, N.S., et al. (2005): Bi-annual surge of Crimean-Congo haemorrhagic fever (CCHF): a five-year experience. Int. J. Infect. Dis., 9, 37-42.